...
首页> 外文期刊>British Journal of Pharmacology >Cyclic GMP, sodium nitroprusside and sodium azide reduce aqueous humour formation in the isolated arterially perfused pig eye
【24h】

Cyclic GMP, sodium nitroprusside and sodium azide reduce aqueous humour formation in the isolated arterially perfused pig eye

机译:循环GMP,硝普钠和叠氮化钠可减少离体动脉灌注猪眼的房水形成

获取原文
获取原文并翻译 | 示例

摘要

1. The effect of nitric oxide (NO) on aqueous humour formation (AHF) and intraocular pressure (IOP) was studied using NO donors, sodium azide (AZ) and sodium nitroprusside (SNP). 2. Using the porcine arterially perfused eye preparation, drug effects on AHF and IOP were measured by fluorescein dilution and manometry, respectively. Perfusion pressure of the "ocular vasculature was also monitored using digital pressure transducer and pen recorder. 3. L-Arginine (l.OmM), a precursor of NO, but not D-arginine (l.OmM), the inactive analogue, produced a significant reduction in AHF (28.5%) and IOP (21.1%). L-NAME (L-nitro-L-arginine) (10-100 μM), an NO synthase inhibitor, had no effect on AHF and IOP. However, L-NAME (100 μM) completely reversed L-arginine's effect. 4. AZ and SNP reduced the AHF and IOP dose-dependently. AZ at 100 nM, 1 and 10 μM reduced AHF by 26.0, 39.7 and 51.7% and IOP by 10.8, 17.3 and 24.0%, respectively. SNP at 1, 10 and 100 μM reduced the AHF by 6.0, 24.2 and 35.4% and IOP by 3.5, 9.5 and 15.5%, respectively. 8-pCPT-cGMP (8-para-chlorophenyl-thioguanosine-3′,5′-cyclic guanosine monophosphate, 10 μM), a cGMP analogue, also reduced the AHF (34.9%) and IOP (15.9%). 5. The effects of AZ and SNP on the AHF and IOP were blocked by a soluble guanylate cyclase inhibitor ODQ (10 μM), whereas ODQ alone or combined with 8-pCPT-cGMP had no effect on the AHF and IOP. 6. None of the drugs had any significant effect on ocular vasculature. 7. The reduction of the AHF and IOP in the arterially perfused pig eye by nitrovasodilators is likely to involve the NO-cGMP pathway.
机译:1.使用NO供体,叠氮化钠(AZ)和硝普钠(SNP)研究了一氧化氮(NO)对房水形成(AHF)和眼内压(IOP)的影响。 2.使用猪动脉灌注眼制剂,分别通过荧光素稀释和测压法测量对AHF和IOP的药物作用。还使用数字压力传感器和笔记录器监测“眼的脉管系统的灌注压力。” 3.产生了NO的前体L-精氨酸(1.0mM),但没有产生非活性类似物D-精氨酸(1.0mM)。明显降低了AHF(28.5%)和IOP(21.1%); NO合酶抑制剂L-NAME(L-硝基-L-精氨酸)(10-100μM)对AHF和IOP没有影响。 L-NAME(100μM)完全逆转了L-精氨酸的作用; 4。AZ和SNP剂量依赖性地降低了AHF和IOP; 100 nM,1和10μM的AZ使AHF降低了26.0、39.7和51.7%,IOP降低了10.8。分别为17.3和24.0%。1、10和100μM的SNP可使AHF分别降低6.0、24.2和35.4%,IOP分别降低3.5、9.5和15.5%。8-pCPT-cGMP(8-对氯苯基- cGMP类似物thioguanosine-3′,5′-环鸟苷一磷酸(10μM)也降低了AHF(34.9%)和IOP(15.9%)。5. AZ和SNP对AHF和IOP的作用被阻断通过可溶性鸟苷酸环化酶抑制剂ODQ(10μM)进行,而单独使用ODQ或与8-pCPT-cGMP联合使用对AHF和IOP无影响。 6.没有一种药物对眼部血管有明显影响。 7.硝基血管扩张剂减少动脉灌注的猪眼中的AHF和IOP可能涉及NO-cGMP途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号